Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Birke Bartosch1, Jean Dubuisson, François-Loïc Cosset

  • 1Laboratoire de Vectorologie Rétrovirale et Thérapie Génique, Institut National de la Santé et de la Recherche Médicale U412, IFR 128, Ecole Normale Supérieure de Lyon, 69364 Lyon Cedex 07, France.

The Journal of Experimental Medicine
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cytosolic Zinc Finger Domain Structure of the CCHFV Glycoprotein n Is Maintained in Its Membrane-Bound Form.

Journal of the American Chemical Society·2026
Same author

The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production.

Emerging microbes & infections·2026
Same author

Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps.

Vaccines·2026
Same author

Catch me if you can! Is there protection from HCV (re)infection?

Gut·2026
Same author

IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures.

Cell death & disease·2025
Same author

TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence.

Journal of innate immunity·2025

Researchers developed infectious hepatitis C virus (HCV) pseudo-particles to study viral entry. These particles enable new antiviral therapy development for chronic liver disease.

Area of Science:

  • Virology
  • Hepatology
  • Immunology

Background:

  • Hepatitis C virus (HCV) is a major cause of chronic liver disease.
  • Lack of a robust cell culture system has hindered HCV replication studies.
  • Developing effective antiviral therapies for HCV remains a critical need.

Purpose of the Study:

  • To generate infectious HCV pseudo-particles for studying viral entry mechanisms.
  • To investigate the role of HCV glycoproteins in cell infection.
  • To explore potential cellular receptors involved in HCV cell entry.

Main Methods:

  • Assembly of infectious pseudo-particles displaying unmodified HCV glycoproteins (E1 and E2) onto retroviral and lentiviral core particles.
  • Incorporation of a green fluorescent protein (GFP) marker gene for infectivity assessment.

Related Experiment Videos

  • In vitro infection studies using primary hepatocytes and hepato-carcinoma cell lines.
  • Neutralization assays using patient sera and anti-E2 monoclonal antibodies.
  • Investigation of low-density lipoprotein receptor (LDLr) and CD81 as potential HCV receptors.

    • Main Results:

    • Successfully generated functional HCV pseudo-particles capable of mediating infection.
    • Infectivity was dependent on both E1 and E2 HCV glycoproteins.
    • Primary hepatocytes and hepato-carcinoma cells were identified as major in vitro targets.
    • Pseudo-particle infectivity was neutralized by HCV-infected patient sera and some anti-E2 antibodies.
    • Evidence suggests LDLr and CD81 are insufficient for mediating HCV cell entry.

    Conclusions:

    • HCV pseudo-particles effectively mimic early HCV infection steps.
    • These pseudo-particles are valuable tools for studying HCV entry and developing novel antiviral strategies.
    • Further research is needed to fully elucidate the role of cellular receptors in HCV infection.